Form 4: OptimizeRx Director Receives Stock Units

OptimizeRx Corp. reports a grant of restricted stock units to Director Ellen O'Connor Vos.

Summary

• Ellen O'Connor Vos, a Director at OptimizeRx Corp., was granted 34,517 restricted stock units (RSUs) on June 9, 2026.
• These RSUs represent a contingent right to receive shares of OptimizeRx common stock.
• The RSUs are set to vest in full on the earlier of the first anniversary of the grant date or the date of the Company's next annual shareholder meeting.
• Following this transaction, Vos beneficially owns 107,159 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation event for a director rather than a significant financial or strategic development.

Positives

• Director Ellen O'Connor Vos received a significant grant of 34,517 restricted stock units, indicating continued investment and alignment with the company's performance.
• The vesting schedule ties the RSUs to company performance milestones (next annual meeting) or a one-year anniversary, aligning management incentives with long-term shareholder value.

Future Outlook

The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.

Industry Context

StockSavvy.ai notes that grants of restricted stock units to directors are a common form of executive compensation in the healthcare technology sector, designed to incentivize long-term performance and align executive interests with shareholders.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns their interests with long-term company performance, potentially benefiting shareholders if the stock price appreciates.
• Employees: This filing is primarily related to director compensation and has no direct impact on general employees.

Next Steps

• Vesting of restricted stock units on the earlier of the first anniversary of the grant date or the company's next annual shareholder meeting.

Key Dates

Keywords

OptimizeRx Corp, OPRX, Form 4, SEC Filing, Restricted Stock Units, RSU Grant, Director Compensation, Beneficial Ownership, Ellen O'Connor Vos